Precision Biosciences (DTIL) Asset Utilization Ratio (2019 - 2026)

Precision Biosciences (DTIL) has 8 years of Asset Utilization Ratio data on file, last reported at 0.3 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 22.95% year-over-year to 0.3 in Q1 2026; TTM through Mar 2026 was 0.3, a 22.95% decrease from a year earlier, with the FY2025 full-year figure at 0.24, down 49.2% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.3, up from 0.28 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for DTIL reached as high as 0.52 in Q1 2022 and fell as low as 0.01 in Q3 2025.
• Historically, Asset Utilization Ratio has averaged 0.27 across 5 years, with a median of 0.3 in 2023.
• Across the five-year window, Asset Utilization Ratio surged 312.5% in 2023 and plunged 98.54% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.1 in 2022, then surged by 205.43% to 0.3 in 2023, then jumped by 57.76% to 0.47 in 2024, then sank by 41.73% to 0.28 in 2025, then climbed by 9.33% to 0.3 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.3 in Q1 2026, 0.28 in Q4 2025, and 0.01 in Q3 2025.